Markets:

Overview

News

Currencies

International

Treasuries

Tourmaline Bio, Inc. - Common Stock (NQ:TRML)

47.98 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 27, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tourmaline Bio, Inc. - Common Stock

< Previous 1 2 3 Next >

TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024 ↗

May 13, 2024

TRML stock results show that Tourmaline Bio beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 13, 2024

From Tourmaline Bio, Inc.

Via GlobeNewswire

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

April 02, 2024

From Avalo Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 21, 2024

Via Benzinga

TRML Stock Earnings: Tourmaline Bio Reported Results for Q4 2023 ↗

March 19, 2024

Tourmaline Bio just reported results for the fourth quarter of 2023.

Via InvestorPlace

Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 21, 2024

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance.

Via Benzinga

Dow Jumps 200 Points; US Weekly Jobless Claims Fall ↗

March 21, 2024

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.52% to 39,718.37 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Argenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results ↗

March 21, 2024

Investors saw Chugai's experimental drug as a potential rival to Argenx's approved medicine, Vyvgart.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 21, 2024

Via Benzinga

Five Below Posts Q4 Results, Joins LexinFintech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

March 21, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Thursday.

Via Benzinga

Topics Stocks

Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

March 19, 2024

From Tourmaline Bio, Inc.

Via GlobeNewswire

Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

January 29, 2024

From Tourmaline Bio, Inc.

Via GlobeNewswire

Tourmaline Bio Announces Pricing of Public Offering of Common Stock

January 25, 2024

From Tourmaline Bio, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 24, 2024

Via Benzinga

Tourmaline Bio Announces Proposed Public Offering of Common Stock

January 24, 2024

From Tourmaline Bio, Inc.

Via GlobeNewswire

Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)

January 08, 2024

From Tourmaline Bio, Inc.

Via GlobeNewswire

TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday ↗

January 03, 2024

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...

Via Benzinga

Topics Stocks

Bristol Myers Squibb’s big buys: $18.1 billion in 2 biotech deals

December 29, 2023

Bristol Myers announced two acquisitions in a week. The pharma giant is boosting its neuroscience pipeline with Karuna and its oncology pipeline with RayzeBio.

Via MarketBeat

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday ↗

December 22, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition...

Via Benzinga

Topics Stocks

Tourmaline Bio added to the NASDAQ Biotechnology Index

December 15, 2023

From Tourmaline Bio, Inc.

Via GlobeNewswire

Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board

December 14, 2023

From Tourmaline Bio, Inc.

Via GlobeNewswire

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 31, 2023

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.